Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

James K. Rowlett, Ph.D.

TitleAssociate Professor of Psychiatry
InstitutionHarvard Medical School
DepartmentPsychiatry
AddressN.E. Reg. Primate Research Ctr
Behavioral Biology
1 Pine Hill Dr
Southborough MA 01772
Phone508/624-8036
Fax508/624-8197

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Makaron L, Moran CA, Namjoshi O, Rallapalli S, Cook JM, Rowlett JK. Cognition-impairing effects of benzodiazepine-type drugs: Role of GABAA receptor subtypes in an executive function task in rhesus monkeys. Pharmacol Biochem Behav. 2013 Mar; 104:62-8.
    View in: PubMed
  2. Namjoshi OA, Wang ZJ, Rallapalli SK, Johnson EM, Johnson YT, Ng H, Ramerstorfer J, Varagic Z, Sieghart W, Majumder S, Roth BL, Rowlett JK, Cook JM. Search for a3ß(2/3)?2 subtype selective ligands that are stable on human liver microsomes. Bioorg Med Chem. 2013 Jan 1; 21(1):93-101.
    View in: PubMed
  3. Rüedi-Bettschen D, Rowlett JK, Rallapalli S, Clayton T, Cook JM, Platt DM. Modulation of a5 Subunit-Containing GABAA Receptors Alters Alcohol Drinking by Rhesus Monkeys. Alcohol Clin Exp Res. 2013 Apr; 37(4):624-34.
    View in: PubMed
  4. Birkett MA, Shinday NM, Kessler EJ, Meyer JS, Ritchie S, Rowlett JK. Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice. Pharmacol Biochem Behav. 2011 Jun; 98(4):544-51.
    View in: PubMed
  5. Fischer BD, Rowlett JK. Anticonflict and reinforcing effects of triazolam + pregnanolone combinations in rhesus monkeys. J Pharmacol Exp Ther. 2011 Jun; 337(3):805-11.
    View in: PubMed
  6. Fischer BD, Atack JR, Platt DM, Reynolds DS, Dawson GR, Rowlett JK. Contribution of GABA(A) receptors containing a3 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys. Psychopharmacology (Berl). 2011 May; 215(2):311-9.
    View in: PubMed
  7. Rowlett JK, Kehne JH, Sprenger KJ, Maynard GD. Emergence of anti-conflict effects of zolpidem in rhesus monkeys following extended post-injection intervals. Psychopharmacology (Berl). 2011 Apr; 214(4):855-62.
    View in: PubMed
  8. Licata SC, Rowlett JK. Self-administration of bretazenil under progressive-ratio schedules: behavioral economic analysis of the role intrinsic efficacy plays in the reinforcing effects of benzodiazepines. Drug Alcohol Depend. 2011 Jan 15; 113(2-3):157-64.
    View in: PubMed
  9. Fischer BD, Licata SC, Edwankar RV, Wang ZJ, Huang S, He X, Yu J, Zhou H, Johnson EM, Cook JM, Furtmüller R, Ramerstorfer J, Sieghart W, Roth BL, Majumder S, Rowlett JK. Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure. Neuropharmacology. 2010 Dec; 59(7-8):612-8.
    View in: PubMed
  10. Platt DM, Rowlett JK, Spealman RD. Asymmetric generalization and interaction profiles in rhesus monkeys discriminating intravenous cocaine or intravenous heroin from vehicle. J Pharmacol Exp Ther. 2010 Mar; 332(3):985-95.
    View in: PubMed
  11. Rüedi-Bettschen D, Rowlett JK, Spealman RD, Platt DM. Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms. Psychopharmacology (Berl). 2010 Jun; 210(2):169-77.
    View in: PubMed
  12. Licata SC, Platt DM, Rüedi-Bettschen D, Atack JR, Dawson GR, Van Linn ML, Cook JM, Rowlett JK. Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypes. Neuropharmacology. 2010 Feb; 58(2):357-64.
    View in: PubMed
  13. Achat-Mendes C, Valdez GR, Platt DM, Rowlett JK, Spealman RD. Intravenous self-administration of etonitazene alone and combined with cocaine in rhesus monkeys: comparison with heroin and antagonism by naltrexone and naloxonazine. Psychopharmacology (Berl). 2009 Jun; 204(3):489-98.
    View in: PubMed
  14. Licata SC, Platt DM, Cook JM, Van Linn ML, Rowlett JK. Contribution of alpha1 subunit-containing gamma-aminobutyric acidA (GABAA) receptors to motor-impairing effects of benzodiazepines in squirrel monkeys. Psychopharmacology (Berl). 2009 Apr; 203(3):539-46.
    View in: PubMed
  15. Han D, Holger Försterling F, Li X, Deschamps JR, Parrish D, Cao H, Rallapalli S, Clayton T, Teng Y, Majumder S, Sankar S, Roth BL, Sieghart W, Furtmuller R, Rowlett JK, Weed MR, Cook JM. A study of the structure-activity relationship of GABA(A)-benzodiazepine receptor bivalent ligands by conformational analysis with low temperature NMR and X-ray analysis. Bioorg Med Chem. 2008 Oct 1; 16(19):8853-62.
    View in: PubMed
  16. Platt DM, Rowlett JK, Spealman RD. Attenuation of cocaine self-administration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine. Psychopharmacology (Berl). 2008 Oct; 200(2):167-76.
    View in: PubMed
  17. Licata SC, Rowlett JK. Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond. Pharmacol Biochem Behav. 2008 Jul; 90(1):74-89.
    View in: PubMed
  18. Valdez GR, Platt DM, Rowlett JK, Rüedi-Bettschen D, Spealman RD. Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms. J Pharmacol Exp Ther. 2007 Nov; 323(2):525-33.
    View in: PubMed
  19. Rowlett JK, Lelas S. Comparison of zolpidem and midazolam self-administration under progressive-ratio schedules: consumer demand and labor supply analyses. Exp Clin Psychopharmacol. 2007 Aug; 15(4):328-37.
    View in: PubMed
  20. Platt DM, Rowlett JK, Spealman RD. Noradrenergic mechanisms in cocaine-induced reinstatement of drug seeking in squirrel monkeys. J Pharmacol Exp Ther. 2007 Aug; 322(2):894-902.
    View in: PubMed
  21. Rowlett JK, Platt DM, Yao WD, Spealman RD. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys. J Pharmacol Exp Ther. 2007 Jun; 321(3):1135-43.
    View in: PubMed
  22. Duke AN, Platt DM, Cook JM, Huang S, Yin W, Mattingly BA, Rowlett JK. Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes. Psychopharmacology (Berl). 2006 Aug; 187(3):321-30.
    View in: PubMed
  23. Rowlett JK, Lelas S, Tornatzky W, Licata SC. Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABAA receptors. Psychopharmacology (Berl). 2006 Jan; 184(2):201-11.
    View in: PubMed
  24. Rowlett JK. Getting back to basics: commentary on McSweeney, Murphy, and Kowal (2005). Exp Clin Psychopharmacol. 2005 Aug; 13(3):187-9; discussion 194-9.
    View in: PubMed
  25. Tiefenbacher S, Fahey MA, Rowlett JK, Meyer JS, Pouliot AL, Jones BM, Novak MA. The efficacy of diazepam treatment for the management of acute wounding episodes in captive rhesus macaques. Comp Med. 2005 Aug; 55(4):387-92.
    View in: PubMed
  26. Licata SC, Platt DM, Cook JM, Sarma PV, Griebel G, Rowlett JK. Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one]. J Pharmacol Exp Ther. 2005 Jun; 313(3):1118-25.
    View in: PubMed
  27. Platt DM, Duggan A, Spealman RD, Cook JM, Li X, Yin W, Rowlett JK. Contribution of alpha 1GABAA and alpha 5GABAA receptor subtypes to the discriminative stimulus effects of ethanol in squirrel monkeys. J Pharmacol Exp Ther. 2005 May; 313(2):658-67.
    View in: PubMed
  28. Rowlett JK, Platt DM, Lelas S, Atack JR, Dawson GR. Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc Natl Acad Sci U S A. 2005 Jan 18; 102(3):915-20.
    View in: PubMed
  29. Rowlett JK, Cook JM, Duke AN, Platt DM. Selective antagonism of GABAA receptor subtypes: an in vivo approach to exploring the therapeutic and side effects of benzodiazepine-type drugs. CNS Spectr. 2005 Jan; 10(1):40-8.
    View in: PubMed
  30. Rowlett JK, Rodefer JS, Spealman RD. Self-Administration of cocaine-opioid combinations by rhesus monkeys: evaluation of the role of mu receptor efficacy using labor supply analysis. J Pharmacol Exp Ther. 2005 Mar; 312(3):1289-97.
    View in: PubMed
  31. Lee B, Platt DM, Rowlett JK, Adewale AS, Spealman RD. Attenuation of behavioral effects of cocaine by the Metabotropic Glutamate Receptor 5 Antagonist 2-Methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: comparison with dizocilpine. J Pharmacol Exp Ther. 2005 Mar; 312(3):1232-40.
    View in: PubMed
  32. Rowlett JK, Platt DM, Spealman RD. Cocaine-like discriminative stimulus effects of heroin: modulation by selective monoamine transport inhibitors. J Pharmacol Exp Ther. 2004 Jul; 310(1):342-8.
    View in: PubMed
  33. Spealman RD, Lee B, Tiefenbacher S, Platt DM, Rowlett JK, Khroyan TV. Triggers of relapse: nonhuman primate models of reinstated cocaine seeking. Nebr Symp Motiv. 2004; 50:57-84.
    View in: PubMed
  34. de Almeida RM, Rowlett JK, Cook JM, Yin W, Miczek KA. GABAA/alpha1 receptor agonists and antagonists: effects on species-typical and heightened aggressive behavior after alcohol self-administration in mice. Psychopharmacology (Berl). 2004 Mar; 172(3):255-63.
    View in: PubMed
  35. Platt DM, Rowlett JK, Izenwasser S, Spealman RD. Opioid partial agonist effects of 3-O-methylnaltrexone in rhesus monkeys. J Pharmacol Exp Ther. 2004 Mar; 308(3):1030-9.
    View in: PubMed
  36. Khroyan TV, Platt DM, Rowlett JK, Spealman RD. Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates. Psychopharmacology (Berl). 2003 Jul; 168(1-2):124-31.
    View in: PubMed
  37. Platt DM, Rodefer JS, Rowlett JK, Spealman RD. Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys. Psychopharmacology (Berl). 2003 Mar; 166(3):298-305.
    View in: PubMed
  38. Rowlett JK, Spealman RD, Lelas S, Cook JM, Yin W. Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors. Psychopharmacology (Berl). 2003 Jan; 165(3):209-15.
    View in: PubMed
  39. Rowlett JK, Rodefer JS, Spealman RD. Self-administration of cocaine, alfentanil, and nalbuphine under progressive-ratio schedules: consumer demand and labor supply analyses of relative reinforcing effectiveness. Exp Clin Psychopharmacol. 2002 Nov; 10(4):367-75.
    View in: PubMed
  40. Platt DM, Rowlett JK, Spealman RD, Cook J, Ma C. Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys. Psychopharmacology (Berl). 2002 Nov; 164(2):151-9.
    View in: PubMed
  41. Platt DM, Rowlett JK, Spealman RD. Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology (Berl). 2002 Oct; 163(3-4):265-82.
    View in: PubMed
  42. Park WK, Bari AA, Jey AR, Anderson SM, Spealman RD, Rowlett JK, Pierce RC. Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens. J Neurosci. 2002 Apr 1; 22(7):2916-25.
    View in: PubMed
  43. Lelas S, Rowlett JK, Spealman RD, Cook JM, Ma C, Li X, Yin W. Role of GABAA/benzodiazepine receptors containing alpha 1 and alpha 5 subunits in the discriminative stimulus effects of triazolam in squirrel monkeys. Psychopharmacology (Berl). 2002 May; 161(2):180-8.
    View in: PubMed
  44. Lelas S, Rowlett JK, Spealman RD. Isobolographic analysis of chlordiazepoxide and triazolam combinations in squirrel monkeys discriminating triazolam. Psychopharmacology (Berl). 2001 Nov; 158(2):181-9.
    View in: PubMed
  45. Platt DM, Rowlett JK, Spealman RD. Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergic mechanisms. J Pharmacol Exp Ther. 2001 Nov; 299(2):760-7.
    View in: PubMed
  46. Rowlett JK, Spealman RD, Platt DM. Similar enhancement of the discriminative stimulus effects of cocaine and GBR 12909 by heroin in squirrel monkeys. Psychopharmacology (Berl). 2001 Sep; 157(3):313-9.
    View in: PubMed
  47. Platt DM, Rowlett JK, Spealman RD. Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys. Psychopharmacology (Berl). 2001 Sep; 157(2):208-16.
    View in: PubMed
  48. Rowlett JK, Tornatzky W, Cook JM, Ma C, Miczek KA. Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-Carboline-3-carboxylate-t-butyl ester (beta-CCt). J Pharmacol Exp Ther. 2001 Apr; 297(1):247-53.
    View in: PubMed
  49. Lelas S, Rowlett JK, Spealman RD. Triazolam discrimination in squirrel monkeys distinguishes high-efficacy agonists from other benzodiazepines and non-benzodiazepine drugs. Psychopharmacology (Berl). 2001 Feb; 154(1):96-104.
    View in: PubMed
  50. Rowlett JK, Woolverton WL. Discriminative stimulus effects of panadiplon (U-78875), a partial agonist at the benzodiazepine site, in pentobarbital-trained rhesus monkeys. Drug Alcohol Depend. 2001 Feb 1; 61(3):229-36.
    View in: PubMed
  51. Wilcox KM, Rowlett JK, Paul IA, Ordway GA, Woolverton WL. On the relationship between the dopamine transporter and the reinforcing effects of local anesthetics in rhesus monkeys: practical and theoretical concerns. Psychopharmacology (Berl). 2000 Dec; 153(1):139-47.
    View in: PubMed
  52. Rowlett JK. A labor-supply analysis of cocaine self-administration under progressive-ratio schedules: antecedents, methodologies, and perspectives. Psychopharmacology (Berl). 2000 Dec; 153(1):1-16.
    View in: PubMed
  53. Rowlett JK, Lelas S, Spealman RD. Transduction of the discriminative stimulus effects of zolpidem by GABA(A)/alpha1 receptors. Eur J Pharmacol. 2000 Oct 6; 406(1):R9-R10.
    View in: PubMed
  54. Lelas S, Spealman RD, Rowlett JK. Using behavior to elucidate receptor mechanisms: a review of the discriminative stimulus effects of benzodiazepines. Exp Clin Psychopharmacol. 2000 Aug; 8(3):294-311.
    View in: PubMed
  55. Rowlett JK. Regulation of drug-maintained behavior: comment on Meisch (2000) Exp Clin Psychopharmacol. 2000 Aug; 8(3):355-6; discussion 362-5.
    View in: PubMed
  56. Khroyan TV, Barrett-Larimore RL, Rowlett JK, Spealman RD. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J Pharmacol Exp Ther. 2000 Aug; 294(2):680-7.
    View in: PubMed
  57. Platt DM, Rowlett JK, Spealman RD. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434. J Pharmacol Exp Ther. 2000 Jun; 293(3):1017-26.
    View in: PubMed
  58. Rowlett JK, Spealman RD, Platt DM. Cocaine-like discriminative stimulus effects of heroin in squirrel monkeys: role of active metabolites and opioid receptor mechanisms. Psychopharmacology (Berl). 2000 Jun; 150(2):191-9.
    View in: PubMed
  59. Rush CR, Baker RW, Rowlett JK. Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans. Exp Clin Psychopharmacol. 2000 Feb; 8(1):22-36.
    View in: PubMed
  60. Woolverton WL, Rowlett JK, Wilcox KM, Paul IA, Kline RH, Newman AH, Katz JL. 3'- and 4'-chloro-substituted analogs of benztropine: intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys. Psychopharmacology (Berl). 2000 Jan; 147(4):426-35.
    View in: PubMed
  61. Spealman RD, Khroyan TV, Barrett-Larimore RL, Rowlett JK, Platt DM. Dopaminergic mechanisms in relapse to cocaine-seeking behavior. Implications for medications development. Ann N Y Acad Sci. 2000; 909:273-4.
    View in: PubMed
  62. Rowlett JK, Spealman RD, Lelas S. Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics. J Pharmacol Exp Ther. 1999 Dec; 291(3):1233-41.
    View in: PubMed
  63. Spealman RD, Barrett-Larimore RL, Rowlett JK, Platt DM, Khroyan TV. Pharmacological and environmental determinants of relapse to cocaine-seeking behavior. Pharmacol Biochem Behav. 1999 Oct; 64(2):327-36.
    View in: PubMed
  64. Platt DM, Grech DM, Rowlett JK, Spealman RD. Discriminative stimulus effects of morphine in squirrel monkeys: stimulants, opioids, and stimulant-opioid combinations. J Pharmacol Exp Ther. 1999 Sep; 290(3):1092-100.
    View in: PubMed
  65. Rowlett JK, Wilcox KM, Woolverton WL. Discriminative stimulus effects of ethyl-beta-carboline-3-carboxylate at two training doses in rats. Psychopharmacology (Berl). 1999 Aug; 145(3):324-32.
    View in: PubMed
  66. Rowlett JK, Winger G, Carter RB, Wood PL, Woods JH, Woolverton WL. Reinforcing and discriminative stimulus effects of the neuroactive steroids pregnanolone and Co 8-7071 in rhesus monkeys. Psychopharmacology (Berl). 1999 Jul; 145(2):205-12.
    View in: PubMed
  67. Woolverton WL, Rowlett JK, Winger G, Woods JH, Gerak LR, France CP. Evaluation of the reinforcing and discriminative stimulus effects of gamma-hydroxybutyrate in rhesus monkeys. Drug Alcohol Depend. 1999 Apr 1; 54(2):137-43.
    View in: PubMed
  68. Rowlett JK, Spealman RD. Opioid enhancement of the discriminative stimulus effects of cocaine: evidence for involvement of mu and delta opioid receptors. Psychopharmacology (Berl). 1998 Nov; 140(2):217-24.
    View in: PubMed
  69. Woolverton WL, Rowlett JK. Choice maintained by cocaine or food in monkeys: effects of varying probability of reinforcement. Psychopharmacology (Berl). 1998 Jul; 138(1):102-6.
    View in: PubMed
  70. Rowlett JK, Wilcox KM, Woolverton WL. Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone. J Pharmacol Exp Ther. 1998 Jul; 286(1):61-9.
    View in: PubMed
  71. Rowlett JK, Woolverton WL. Discriminative stimulus effects of benzodiazepine agonists and partial agonists in pentobarbital-trained rhesus monkeys. Behav Pharmacol. 1998 Mar; 9(2):81-92.
    View in: PubMed
  72. France CP, Gerak LR, Rowlett JK, Woolverton WL, Winger G, Woods JH. Progress report from the testing program for stimulant and depressant drugs (1996). NIDA Res Monogr. 1998 Mar; 178:429-39.
    View in: PubMed
  73. Rowlett JK, Woolverton WL. Self-administration of cocaine and heroin combinations by rhesus monkeys responding under a progressive-ratio schedule. Psychopharmacology (Berl). 1997 Oct; 133(4):363-71.
    View in: PubMed
  74. Rowlett JK, Mattingly BA, Bardo MT. Locomotor activity and dopamine synthesis following 1 and 15 days of withdrawal from repeated apomorphine treatments. Pharmacol Biochem Behav. 1997 May-Jun; 57(1-2):13-8.
    View in: PubMed
  75. Rush CR, Madakasira S, Goldman NH, Woolverton WL, Rowlett JK. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans. J Pharmacol Exp Ther. 1997 Jan; 280(1):174-88.
    View in: PubMed
  76. Rowlett JK, Woolverton WL. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats. J Pharmacol Exp Ther. 1997 Jan; 280(1):162-73.
    View in: PubMed
  77. Rowlett JK, Woolverton WL. Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies. Psychopharmacology (Berl). 1996 Nov; 128(1):1-16.
    View in: PubMed
  78. Acteo MD, Bowman E, Butelman E, Englis JA, Harrish L, Jacobson AE, Mattson MV, Medzihradsky F, Patrick G, Rowlett JK, Smith CB, Winger G, Woods JH, Woolverton WL. Zipeprol: preclinical assessment of abuse potential. Drug Alcohol Depend. 1996 Oct; 42(2):93-104.
    View in: PubMed
  79. Rowlett JK, Massey BW, Kleven MS, Woolverton WL. Parametric analysis of cocaine self-administration under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology (Berl). 1996 Jun; 125(4):361-70.
    View in: PubMed
  80. Mattingly BA, Fields SE, Langfels MS, Rowlett JK, Robinet PM, Bardo MT. Repeated 7-OH-DPAT treatments: behavioral sensitization, dopamine synthesis and subsequent sensitivity to apomorphine and cocaine. Psychopharmacology (Berl). 1996 May; 125(1):33-42.
    View in: PubMed
  81. Mattingly BA, Rowlett JK, Ellison T, Rase K. Cocaine-induced behavioral sensitization: effects of haloperidol and SCH 23390 treatments. Pharmacol Biochem Behav. 1996 Mar; 53(3):481-6.
    View in: PubMed
  82. English JA, Rowlett JK, Woolverton WL. Unit-price analysis of opioid consumption by monkeys responding under a progressive-ratio schedule of drug injection. J Exp Anal Behav. 1995 Nov; 64(3):361-71.
    View in: PubMed
  83. Pierce RC, Rowlett JK, Rebec GV, Bardo MT. Ascorbate potentiates amphetamine-induced conditioned place preference and forebrain dopamine release in rats. Brain Res. 1995 Aug 7; 688(1-2):21-6.
    View in: PubMed
  84. Rowlett JK, Mattingly BA, Bardo MT. Repeated quinpirole treatment: locomotor activity, dopamine synthesis, and effects of selective dopamine antagonists. Synapse. 1995 Jul; 20(3):209-16.
    View in: PubMed
  85. Bardo MT, Bowling SL, Rowlett JK, Manderscheid P, Buxton ST, Dwoskin LP. Environmental enrichment attenuates locomotor sensitization, but not in vitro dopamine release, induced by amphetamine. Pharmacol Biochem Behav. 1995 Jun-Jul; 51(2-3):397-405.
    View in: PubMed
  86. Bardo MT, Rowlett JK, Harris MJ. Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci Biobehav Rev. 1995; 19(1):39-51.
    View in: PubMed
  87. Rowlett JK, Gibson TR, Bardo MT. Dissociation of buprenorphine-induced locomotor sensitization and conditioned place preference in rats. Pharmacol Biochem Behav. 1994 Sep; 49(1):241-5.
    View in: PubMed
  88. Crawford CA, Rowlett JK, McDougall SA, Bardo MT. Age-dependent differences in the rate of recovery of striatal dopamine D1 and D2 receptors after inactivation with EEDQ. Eur J Pharmacol. 1994 Feb 3; 252(2):225-31.
    View in: PubMed
  89. Neisewander JL, Nonneman AJ, Rowlett JK, Bardo MT. Impaired supersensitivity to morphine following chronic naltrexone treatment in senescent rats. Neurobiol Aging. 1994 Jan-Feb; 15(1):91-7.
    View in: PubMed
  90. Bowling SL, Rowlett JK, Bardo MT. The effect of environmental enrichment on amphetamine-stimulated locomotor activity, dopamine synthesis and dopamine release. Neuropharmacology. 1993 Sep; 32(9):885-93.
    View in: PubMed
  91. Rowlett JK, Mattingly BA, Bardo MT. Neurochemical correlates of behavioral sensitization following repeated apomorphine treatment: assessment of the role of D1 dopamine receptor stimulation. Synapse. 1993 Jun; 14(2):160-8.
    View in: PubMed
  92. Mattingly BA, Rowlett JK, Lovell G. Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine. Psychopharmacology (Berl). 1993; 110(3):320-6.
    View in: PubMed
  93. Crawford CA, McDougall SA, Rowlett JK, Bardo MT. Depletion of dopamine binding sites and changes in dopamine and dihydroxyphenylacetic acid levels in 17- and 90-day-old rat striatum after irreversible receptor antagonism. Neurosci Lett. 1992 Mar 30; 137(2):265-9.
    View in: PubMed
  94. Blanchard DC, Cholvanich P, Blanchard RJ, Clow DW, Hammer RP, Rowlett JK, Bardo MT. Serotonin, but not dopamine, metabolites are increased in selected brain regions of subordinate male rats in a colony environment. Brain Res. 1991 Dec 24; 568(1-2):61-6.
    View in: PubMed
  95. Rowlett JK, Pedigo NW, Bardo MT. Catalepsy produced by striatal microinjections of the D1 dopamine receptor antagonist SCH 23390 in neonatal rats. Pharmacol Biochem Behav. 1991 Dec; 40(4):829-34.
    View in: PubMed
  96. Rowlett JK, Mattingly BA, Bardo MT. Neurochemical and behavioral effects of acute and chronic treatment with apomorphine in rats. Neuropharmacology. 1991 Feb; 30(2):191-7.
    View in: PubMed
  97. Mattingly BA, Rowlett JK, Graff JT, Hatton BJ. Effects of selective D1 and D2 dopamine antagonists on the development of behavioral sensitization to apomorphine. Psychopharmacology (Berl). 1991; 105(4):501-7.
    View in: PubMed
  98. Pierce RC, Rowlett JK, Bardo MT, Rebec GV. Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding. Neuroscience. 1991; 45(2):373-8.
    View in: PubMed
  99. Mattingly BA, Rowlett JK. Effects of repeated apomorphine and haloperidol treatments on subsequent behavioral sensitivity to apomorphine. Pharmacol Biochem Behav. 1989 Oct; 34(2):345-7.
    View in: PubMed
  100. Neisewander JL, Rowlett JK, Nonneman AJ, Bardo MT. Up-regulation of opiate receptors following chronic naltrexone treatment in mature and aged male and female rats. Prog Clin Biol Res. 1989; 292:471-6.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Rowlett's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
See all (283) concept(s)
_
Co-Authors
See all (8) people
_
Similar People
See all (60) people
_
Same Department
Search Department
Physical Neighbors
_